查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577206

糖尿病足潰瘍治療市場至2030年的預測：按治療類型、潰瘍類型、最終用戶和地區的全球分析

Diabetic Foot Ulcer Treatment Market Forecasts to 2030 - Global Analysis by Treatment Type (Wound Care Dressings, Wound Care Devices, Biologics, Antibiotics and Surgical Procedures), Ulcer Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2024年全球糖尿病足潰瘍治療市場規模為 90.2億美元，預計在預測期內年複合成長率為 8.3%，到2030年將達到 145.5億美元。

糖尿病足潰瘍治療包括各種目的是治癒糖尿病相關併發症引起的潰瘍的醫療和治療性介入。這些治療包括創傷護理管理，例如清創和塗布高級敷料，以及使用抗生素預防感染。在嚴重的情況下，可能需要手術。此外，適當的足部護理和患者有關糖尿病管理的教育在預防潰瘍復發方面發揮著重要作用。最終目標是加速康復、減少併發症並提高受影響個體的生活品質。

糖尿病盛行率上升

糖尿病盛行率的上升對市場產生了重大影響，增加了面臨足部併發症風險的患者數量。隨著糖尿病患者數量的增加，更多的人出現神經病變和血液作用不良，導致足部潰瘍的發生率更高。這一趨勢推動對先進治療方案的需求，例如專門的創傷護理產品和治療方法。此外，醫療保健系統被迫實施全面的管理策略來應對這些挑戰，進一步推動市場成長。

治療費用高

不斷上漲的治療成本限制了許多患者獲得先進治療的機會，並對市場產生重大影響。專門的創傷護理產品和技術的成本阻礙了及時干預，導致併發症增加和病情惡化。這些財務障礙導致治療延誤並最終影響患者的治療結果。這阻礙了市場的成長。

技術進步

隨著智慧敷料、生物活性材料和遠端醫療服務等創新創傷護理解決方案的推出，技術進步改變市場。這些技術可提高治療效果、促進早期癒合並改善患者監測。整合資料分析和行動醫療應用程式可促進個人化護理並改善結果和病人參與。隨著醫療保健提供者採用這些技術，對先進糖尿病足潰瘍治療的需求不斷增加，推動市場成長。

有限的醫療服務

獲得醫療保健的機會有限阻礙了患者的及時診斷和干涉，影響了市場。在服務不足的地區，缺乏醫療設施和專門護理可能會延誤治療並增加感染疾病和截肢等併發症的風險。這種情況會導致患者治療效果不佳並增加長期醫療成本，凸顯了改善醫療基礎設施和可近性以確保有效管理糖尿病足潰瘍的必要性，阻礙了市場成長。

COVID-19 的影響：

COVID-19 大流行導致選擇性手術延遲，並因醫療機構關閉而減少患者就診次數，對糖尿病足潰瘍治療市場產生了負面影響。這導致糖尿病患者的併發症增加和病情惡化。然而，這場危機也刺激了遠端醫療和遠距監控領域的創新，改善了治療的可近性。

神經病變潰瘍領域預計將成為預測期內最大的

預計預測期內神經病變潰瘍領域將是最大的，因為神經病變潰瘍通常是由神經損傷引起的，導致感覺下降和無法識別的損傷。神經病變潰瘍的盛行率不斷增加，推動了對專業治療和高級護理解決方案的需求。隨著醫療保健提供者致力於定期篩檢和客製化治療等綜合管理策略，糖尿病足潰瘍治療市場持續擴大，強調了解決患者照護中神經病變病變的重要性。

醫院部門預計在預測期內年複合成長率最高

醫院部門預計在預測期內將出現最高的年複合成長率，因為其對包括足病學、創傷護理和糖尿病管理在內的多學科方法的關注將改善患者的治療效果。該醫院還幫助提高人們對早期療育和預防性護理重要性的認知。此外，對先進技術和創傷護理產品的投資推動市場創新，並提高整個醫療系統糖尿病足潰瘍治療的可及性和效率。

佔有率最大的地區

由於糖尿病及其併發症的盛行率不斷上升，預計北美在預測期內將佔據最大的市場佔有率。創新的治療方法和先進的創傷護理技術可改善患者管理並降低感染疾病和截肢的風險。這一市場成長將改善獲得有效治療的機會，最終提高患者的生活品質。醫療保健提供者的認知不斷提高，進一步強調了預防保健和及時干預的重要性，促進了該地區糖尿病足潰瘍的綜合管理方法。

年複合成長率最高的地區：

由於糖尿病及相關併發症的盛行率不斷上升，預計亞太地區在預測期內將呈現最高的年複合成長率。對適當足部護理的認知不斷提高以及治療技術的進步推動對有效治療方法的需求。此外，目的是改善糖尿病管理和醫療基礎設施的政府措施日益增加獲得治療的機會。人口老化和肥胖率上升進一步推動了該成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之1：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球糖尿病足潰瘍治療市場：依治療類型

  • 創傷護理敷料
    • 泡棉敷料
    • 親水膠體敷料
    • 藻酸鹽敷料
    • 水凝膠敷料
    • 其他高級敷料
  • 創傷護理設備
    • 負壓傷口治療法（NPWT）
    • 超音波治療儀
    • 高壓氧氣療法（HBOT）
    • 電刺激設備
  • 生物製藥
    • 皮膚替代品
    • 組織工程產品
  • 抗生素
    • 局部抗生素
    • 口服抗生素
  • 外科手術
    • 清創術
    • 重組
    • 植皮

第6章 全球糖尿病足潰瘍治療市場：依潰瘍類型

  • 神經病變潰瘍
  • 缺血性潰瘍
  • 神經缺血性潰瘍

第7章 全球糖尿病足潰瘍治療市場：依最終用戶分類

  • 醫院
  • 專科診所
  • 門診手術中心
  • 居家照護環境
  • 其他最終用戶

第8章 全球糖尿病足潰瘍治療市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章 公司概況

  • 3M Healthcare
  • Acelity LP Inc.（KCI）
  • Advanced Tissue
  • Alliqua Biomedical, Inc.
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group Plc
  • Derma Sciences Inc.
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Medline Industries, Inc.
  • Medtronic Plc
  • Molnlycke Health Care AB
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Paul Hartmann AG
  • Smith & Nephew Plc
  • Wound Care Innovations, LLC
Product Code: SMRC27524

According to Stratistics MRC, the Global Diabetic Foot Ulcer Treatment Market is accounted for $9.02 billion in 2024 and is expected to reach $14.55 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Diabetic foot ulcer treatment encompasses a range of medical and therapeutic interventions aimed at healing ulcers resulting from diabetes-related complications. These treatments include wound care management, such as debridement and the application of advanced dressings, as well as the use of antimicrobial agents to prevent infection. In severe cases, surgical interventions may be necessary. Additionally, patient education on proper foot care and diabetes management plays a vital role in preventing ulcer recurrence. The ultimate goal is to promote healing, reduce complications, and enhance the quality of life for affected individuals.

Market Dynamics:

Driver:

Rising Diabetes Prevalence

Rising diabetes prevalence significantly impacts the market by increasing the number of patients at risk for foot complications. As diabetes cases grow, more individuals experience neuropathy and poor circulation, leading to a higher incidence of foot ulcers. This trend drives demand for advanced treatment options, including specialized wound care products and therapies. Additionally, healthcare systems are compelled to implement comprehensive management strategies to address these challenges, further fueling market growth.

Restraint:

High Treatment Costs

High treatment costs significantly impact the market by limiting access to advanced therapies for many patients. The expense associated with specialized wound care products and technologies can discourage timely intervention, leading to increased complications and worsening conditions. This financial barrier may result in delayed treatment, ultimately affecting patient outcomes. Thus, it hinders the growth opf the market.

Opportunity:

Advancements in Technology

Advancements in technology are transforming the market by introducing innovative wound care solutions, such as smart dressings, bioactive materials, and telehealth services. These technologies enhance the effectiveness of treatment, promote faster healing, and allow for better patient monitoring. The integration of data analytics and mobile health applications facilitates personalized care, improving outcomes and patient engagement. As healthcare providers increasingly adopt these technologies, the demand for advanced diabetic foot ulcer treatments grows, thus it drives the growth of the market.

Threat:

Limited Healthcare Access

Limited healthcare access impacts the market by hindering timely diagnosis and intervention for patients. In underserved regions, a lack of medical facilities and specialized care can result in delayed treatments, increasing the risk of complications like infections and amputations. This scenario leads to poorer patient outcomes and higher long-term healthcare costs, emphasizing the need for improved healthcare infrastructure and accessibility to ensure effective management of diabetic foot ulcers, thus it hampers the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic adversely affected the diabetic foot ulcer treatment market by causing delays in elective procedures and reducing patient visits to healthcare facilities due to lockdowns. This leads to increased complications and worsening conditions among diabetic patients. However, the crisis also spurred innovation in telehealth and remote monitoring, improving access to care.

The neuropathic ulcers segment is expected to be the largest during the forecast period

The neuropathic ulcers segment is expected to be the largest during the forecast period as these ulcers often result from nerve damage, leading to reduced sensation and unrecognized injuries. The growing prevalence of neuropathic ulcers drives demand for specialized treatments and advanced care solutions. As healthcare providers focus on comprehensive management strategies, including regular screening and tailored therapies, the market for diabetic foot ulcer treatments continues to expand, emphasizing the importance of addressing neuropathic conditions in patient care.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the forecast period because Increased focus on multidisciplinary approaches, including podiatry, wound care, and diabetes management, enhances patient outcomes. Hospitals are also instrumental in raising awareness about the importance of early intervention and preventative care. Moreover, their investment in advanced technologies and wound care products drives innovation in the market, improving accessibility and efficiency in treating diabetic foot ulcers across the healthcare system.

Region with largest share:

North America is projected to hold the largest market share during the forecast period as it addresses the rising incidence of diabetes and its complications. Innovative therapies and advanced wound care technologies improve patient management, reducing the risk of infections and amputations. This market's growth enhances access to effective treatments, ultimately leading to better patient quality of life. Increased awareness among healthcare providers further emphasizes the importance of preventative care and timely intervention, fostering a comprehensive approach to managing diabetic foot ulcers in the region.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period owing to rising prevalence of diabetes and related complications. Increasing awareness of proper foot care and advancements in treatment technologies are driving demand for effective therapies. Additionally, government initiatives aimed at improving diabetes management and healthcare infrastructure are enhancing access to treatments. This growth is further supported by the expanding aging population and the increasing incidence of obesity.

Key players in the market

Some of the key players in Diabetic Foot Ulcer Treatment Market include 3M Healthcare, Acelity L.P. Inc. (KCI), Advanced Tissue, Alliqua Biomedical, Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group Plc, Derma Sciences Inc., Hollister Incorporated, Integra LifeSciences Corporation, Medline Industries, Inc., Medtronic Plc, Molnlycke Health Care AB, Organogenesis Inc., Osiris Therapeutics, Inc., Paul Hartmann AG, Smith & Nephew Plc and Wound Care Innovations, LLC.

Key Developments:

In August 2024, Cardinal Health expanded medical product distribution footprint in Northeast Ohio, to support its U.S. Medical Products and Distribution business.

In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.

In September 2023, Cardinal Health announced the U.S. launch of its Kangaroo OMNI Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey.

Treatment Types Covered:

  • Wound Care Dressings
  • Wound Care Devices
  • Biologics
  • Antibiotics
  • Surgical Procedures

Ulcer Types Covered:

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuroischemic Ulcers

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Diabetic Foot Ulcer Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Wound Care Dressings
    • 5.2.1 Foam Dressings
    • 5.2.2 Hydrocolloid Dressings
    • 5.2.3 Alginate Dressings
    • 5.2.4 Hydrogel Dressings
    • 5.2.5 Other Advanced Dressings
  • 5.3 Wound Care Devices
    • 5.3.1 Negative Pressure Wound Therapy (NPWT)
    • 5.3.2 Ultrasound Therapy Devices
    • 5.3.3 Hyperbaric Oxygen Therapy (HBOT)
    • 5.3.4 Electrical Stimulation Devices
  • 5.4 Biologics
    • 5.4.1 Skin Substitutes
    • 5.4.2 Tissue-Engineered Products
  • 5.5 Antibiotics
    • 5.5.1 Topical Antibiotics
    • 5.5.2 Oral Antibiotics
  • 5.6 Surgical Procedures
    • 5.6.1 Debridement
    • 5.6.2 Revascularization
    • 5.6.3 Skin Grafting

6 Global Diabetic Foot Ulcer Treatment Market, By Ulcer Type

  • 6.1 Introduction
  • 6.2 Neuropathic Ulcers
  • 6.3 Ischemic Ulcers
  • 6.4 Neuroischemic Ulcers

7 Global Diabetic Foot Ulcer Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Specialty Clinics
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Home Care Settings
  • 7.6 Other End Users

8 Global Diabetic Foot Ulcer Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Healthcare
  • 10.2 Acelity L.P. Inc. (KCI)
  • 10.3 Advanced Tissue
  • 10.4 Alliqua Biomedical, Inc.
  • 10.5 B. Braun Melsungen AG
  • 10.6 BSN Medical GmbH
  • 10.7 Cardinal Health, Inc.
  • 10.8 Coloplast A/S
  • 10.9 ConvaTec Group Plc
  • 10.10 Derma Sciences Inc.
  • 10.11 Hollister Incorporated
  • 10.12 Integra LifeSciences Corporation
  • 10.13 Medline Industries, Inc.
  • 10.14 Medtronic Plc
  • 10.15 Molnlycke Health Care AB
  • 10.16 Organogenesis Inc.
  • 10.17 Osiris Therapeutics, Inc.
  • 10.18 Paul Hartmann AG
  • 10.19 Smith & Nephew Plc
  • 10.20 Wound Care Innovations, LLC

List of Tables

  • Table 1 Global Diabetic Foot Ulcer Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Diabetic Foot Ulcer Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Diabetic Foot Ulcer Treatment Market Outlook, By Wound Care Dressings (2022-2030) ($MN)
  • Table 4 Global Diabetic Foot Ulcer Treatment Market Outlook, By Foam Dressings (2022-2030) ($MN)
  • Table 5 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)
  • Table 6 Global Diabetic Foot Ulcer Treatment Market Outlook, By Alginate Dressings (2022-2030) ($MN)
  • Table 7 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hydrogel Dressings (2022-2030) ($MN)
  • Table 8 Global Diabetic Foot Ulcer Treatment Market Outlook, By Other Advanced Dressings (2022-2030) ($MN)
  • Table 9 Global Diabetic Foot Ulcer Treatment Market Outlook, By Wound Care Devices (2022-2030) ($MN)
  • Table 10 Global Diabetic Foot Ulcer Treatment Market Outlook, By Negative Pressure Wound Therapy (NPWT) (2022-2030) ($MN)
  • Table 11 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ultrasound Therapy Devices (2022-2030) ($MN)
  • Table 12 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hyperbaric Oxygen Therapy (HBOT) (2022-2030) ($MN)
  • Table 13 Global Diabetic Foot Ulcer Treatment Market Outlook, By Electrical Stimulation Devices (2022-2030) ($MN)
  • Table 14 Global Diabetic Foot Ulcer Treatment Market Outlook, By Biologics (2022-2030) ($MN)
  • Table 15 Global Diabetic Foot Ulcer Treatment Market Outlook, By Skin Substitutes (2022-2030) ($MN)
  • Table 16 Global Diabetic Foot Ulcer Treatment Market Outlook, By Tissue-Engineered Products (2022-2030) ($MN)
  • Table 17 Global Diabetic Foot Ulcer Treatment Market Outlook, By Antibiotics (2022-2030) ($MN)
  • Table 18 Global Diabetic Foot Ulcer Treatment Market Outlook, By Topical Antibiotics (2022-2030) ($MN)
  • Table 19 Global Diabetic Foot Ulcer Treatment Market Outlook, By Oral Antibiotics (2022-2030) ($MN)
  • Table 20 Global Diabetic Foot Ulcer Treatment Market Outlook, By Surgical Procedures (2022-2030) ($MN)
  • Table 21 Global Diabetic Foot Ulcer Treatment Market Outlook, By Debridement (2022-2030) ($MN)
  • Table 22 Global Diabetic Foot Ulcer Treatment Market Outlook, By Revascularization (2022-2030) ($MN)
  • Table 23 Global Diabetic Foot Ulcer Treatment Market Outlook, By Skin Grafting (2022-2030) ($MN)
  • Table 24 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ulcer Type (2022-2030) ($MN)
  • Table 25 Global Diabetic Foot Ulcer Treatment Market Outlook, By Neuropathic Ulcers (2022-2030) ($MN)
  • Table 26 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ischemic Ulcers (2022-2030) ($MN)
  • Table 27 Global Diabetic Foot Ulcer Treatment Market Outlook, By Neuroischemic Ulcers (2022-2030) ($MN)
  • Table 28 Global Diabetic Foot Ulcer Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 30 Global Diabetic Foot Ulcer Treatment Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 31 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 32 Global Diabetic Foot Ulcer Treatment Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 33 Global Diabetic Foot Ulcer Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.